Recordati SpA (MIL:REC)
€ 51.1 0.05 (0.1%) Market Cap: 10.55 Bil Enterprise Value: 11.87 Bil PE Ratio: 25.26 PB Ratio: 5.61 GF Score: 95/100

Q2 2024 Recordati Industria Chimica e Farmaceutica SpA Earnings Call Transcript

Jul 30, 2024 / 02:00PM GMT
Release Date Price: €48.82 (-6.83%)
Operator

Good afternoon. This is the Chorus Call conference operator. Welcome, and thank you for joining the Recordati 2024 first half results conference call. (Operator Instructions)

At this time, I would like to turn the conference over to Ms. Eugenia Litz, Vice President of Investor Relations of Recordati. Please go ahead, madam.

Eugenia Litz;Robert Koremans
Recordati Industria Chimica e Farmaceutica SpA - Vice President, Head of Investor Relations

Thank you, and good afternoon, everyone. I'm pleased to be here today with Rob Koremans, our CEO; and Luigi La Corte, our CFO. Together, they will present results for the first half of 2024. Also joining for the Q&A session will be Alberto Martinez, Executive Vice President of Specialty and Primary Care; Scott Pescatore, Executive Vice President of Rare Diseases; and Milan Zdravkovic, Executive Vice President of R&D. As always, the presentation is available in the Investors section of our website.

It is now my pleasure to pass the call over to Rob. Please go ahead.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot